The chemical and dynamical influence of the anti-viral drug amantadine on the M2 proton channel transmembrane domain

Biophysical Journal

Volumn 93, Issue 1, 2007, Pages 276-283

  Hu, Jun ^a,b   Fu, Riqiang ^b   Cross, Timothy A ^a,b  

^a FLORIDA STATE UNIVERSITY   (United States)

^b FLORIDA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; HISTIDINE; PROTEIN M2;

ARTICLE; DRUG ACTIVITY; DRUG MECHANISM; DRUG PROTEIN BINDING; LIPID BILAYER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; PKA; POLARIZATION; PROTEIN DOMAIN; PROTON TRANSPORT;

INFLUENZA A VIRUS;

EID: 34447258592     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.106.102103     Document Type: Article

References (62)

1. 2 from the influenza A virus. Biochemistry. 39:14160-14170.
2. 2 ion channel from influenza a virus. Biochemistry. 40:6053-6060.
3. 2 transmembrane domain. A circular dichroism study. FEBS Lett. 311:256-258.
4. Astrahan, P., I. Kass, M. A. Cooper, and I. T. Arkin. 2004. A novel method of resistance for influenza against a channel-blocking antiviral drug. Proteins. 55:251-257.
5. Stouffer, A. L., V. Nanda, J. D. Lear, and W. F. DeGrado. 2005. Sequence determinants of a transmembrane proton channel: an inverse relationship between stability and function. J. Mol. Biol. 347:169-179.
6. 2 proton channel from influenza A virus. Biophys. J. In press.
7. Lamb, R. A., and R. M. Krug. 1996. Fields Virology. B. N. Fields, D. M. Knipe, and P. M. Howley, editors. Lippincott-Raven Publishers, Philadelphia, PA.
8. 2 Ion Channel Protein and its Role in the Influenza Virus Life Cycle. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
9. 2 protein: characterization of the amantadine block. J. Virol. 67:5585-5594.
10. 2 ion channel protein. Semin. Virol. 3:21-30.
11. Hay, A. J., A. J. Wolstenholme, J. J. Skehel, and M. H. Smith. 1985. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 4:3021-3024.
12. Kato, N., and H. J. Eggers. 1969. Inhibition of uncoating of fowl plague virus by l-adamantanamine hydrochloride. Virology. 37:632-641.
13. Skehel, J. J., A. J. Hay, and J. A. Armstrong. 1978. On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride. J. Gen. Virol. 38:97-110.
14. 2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment. Virology. 188:14-24.
15. 2 protein of influenza A viruses. Virology. 191:541-549.
16. Skehel, J. J. 1992. Influenza virus. Amantadine blocks the channel. Nature. 358:110-111.
17. Dolin, R., R. C. Reichman, H. P. Madore, R. Maynard, P. N. Linton, and J. Webber-Jones. 1982. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N. Engl. J. Med. 307:580-584.
18. Tsunasawa, S., T. Masaki, M. Hirose, M. Soejima, and F. Sakiyama. 1989. The primary structure and structural characteristics of Achromobacter lyticus protease I, a lysine-specific serine protease. J. Biol. Chem. 264:3832-3839.
19. Bright, R. A., D. Shay, J. Bresee, A. Klimov, N. Cox, and J. Ortiz. 2006. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents. United States, 2005-2006 influenza season. MMWR Morb. Mortal. Wkly. Rep. 55:44-46.
20. Pinto, L. H., and R. A. Lamb. 1995. Understanding the mechanism of action of the anti-influenza virus drug amantadine. Trends Microbiol. 3:271.
21. Aldrich, P. E., E. C. Hermann, W. E. Meier, M. Paulshock, W. W. Prichard, J. A. Snyder, and J. C. Watts. 1971. Antiviral agents. 2. Structure-activity relationships of compounds related to 1-adamantanamine. J. Med. Chem. 14:535-543.
22. Kolocouris, N., A. Kolocouris, G. B. Foscolos, G. Fytas, J. Neyts, E. Padalko, J. Balzarini, R. Snoeck, G. Andrei, and E. De Clercq. 1996. Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2. J. Med. Chem. 39:3307-3318.
23. Scholtissek, C., G. Quack, H. D. Klenk, and R. G. Webster. 1998. How to overcome resistance of influenza A viruses against adamantane derivatives. Antiviral Res. 37:83-95.
24. 2) encoded by RNA segment 7 of influenza virus. Virology. 112:729-737.
25. 2 protein is an integral membrane protein expressed on the infected-cell surface. Cell. 40:627-633.
26. 2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology. 183:32-43.
27. 2 protein of influenza A H1N1 viruses. Virology. 186:352-355.
28. 2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology. 180:617-624.
29. 2 channel expressed in mouse erythroleukemia cells. J. Physiol. 494:329-336.
30. 2 protein in planar lipid bilayers. Biophys. J. 87:1697-1704.
31. 2 ion channel of influenza A virus. J. Biol. Chem. 275:8592-8599.
32. 2 protein forms amantadine-sensitive proton channels in planar lipid bilayers. Virology. 190:485-489.
33. 2 proton channel of influenza A virus suggests a mechanism for its ion selectivity. Proc. Natl. Acad. Sci. USA. 94:11301-11306.
34. 2 channel: a molecular modeling and simulation study. Virology. 233:163-173.
35. Torres, J., A. Kukol, and I. T. Arkin. 2000. Use of a single glycine residue to determine the tilt and orientation of a transmembrane helix. A new structural label for infrared spectroscopy. Biophys. J. 79:3139-3143.
36. + channel. Protein Sci. 10:2241-2250.
37. 2 protein channel: structural implications from helix tilt and orientation. Biophys. J. 73:2511-2517.
38. + channel helical bundle combining precise orientational and distance restraints from solid state NMR. Biochemistry. 41:13170-13177.
39. 2 proton channel depends on lipid bilayer environment. Protein Sci. 14:856-861.
40. 2 protein. J. Biol. Chem. 274:5474-5482.
41. Wu, C. H., A. Ramamoorthy, and S. J. Opella. 1994. High-resolution heteronuclear dipolar solid-state NMR spectroscopy. J. Mag. Res. A. 109:270-272.
42. Ramamoorthy, A., Y. Wei, and D. K. Lee. 2004. PISEMA solid-state NMR spectroscopy. Ann. Rep. NMR Spectrosc. 52:1-52.
43. Barlos, K., D. Papaioannou, and D. Theodoropoulos. 1982. Efficient one-pot synthesis of n-trityl amino acids. J. Org. Chem. 47:1324-1326.
44. Chang, C. D., M. Waki, M. Ahmad, J. Meienhofer, E. O. Lundell, and J. D. Haug. 1980. Preparation and properties of Nα-9- fluorenylmethyloxycarbonylamino acids bearing tert.-butyl side chain protection. Int. J. Pept. Protein Res. 15:59-66.
45. Sanders, C. R., and K. Oxenoid. 2000. Customizing model membranes and samples for NMR spectroscopic studies of complex membrane proteins. Biochim. Biophys. Acta. 1508:129-145.
46. Mimms, L. T., G. Zampighi, Y. Nozaki, C. Tanford, and J. A. Reynolds. 1981. Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside. Biochemistry. 20:833-840.
47. Koynova, R., and M. Caffrey. 1998. Phases and phase transitions of the phosphatidylcholines. Biochim. Biophys. Acta. 1376:91-145.
48. Yamamoto, K., D. K. Lee, and A. Ramamoorthy. 2005. Broadband-PISEMA solid-state NMR spectroscopy. Chem. Phys. Lett. 407:289-293.
49. Yamamoto, K., S. V. Dvinskikh, and A. Ramamoorthy. 2006. Measurement of heteronuclear dipolar couplings using a rotating frame solid-state NMR experiment. Chem. Phys. Lett. 419:533-536.
50. Fu, R., J. Hu, and T. A. Cross. 2004. Towards quantitative measurements in solid-state CPMAS NMR: a Lee-Goldburg frequency modulated cross-polarization scheme. J. Magn. Reson. 168:8-17.
51. Blasco, T., J. Perez-Pariente, and W. Kolodziejski. 1997. A solid-state NMR study of the molecular sieve VPI-5 synthesized in the presence of a CTABr surfactant. Solid State Nucl. Magn. Reson. 8:185-194.
52. Hu, J., R. Fu, K. Nishimura, L. Zhang, H. X. Zhou, D. D. Busath, V. Vijayvergiya, and T. A. Cross. 2006. Histidines, heart of the hydrogen ion channel from influenza A virus: toward an understanding of conductance and proton selectivity. Proc. Natl. Acad. Sci. USA. 103:6865-6870.
53. Blomberg, F., W. Maurer, and H. Ruterjans. 1977. Nuclear magnetic resonance investigation of 15N-labeled histidine in aqueous solution. J. Am. Chem. Soc. 99:8149-8159.
54. 2 proton channel characterized by solid-state nuclear magnetic resonance spectroscopy. PhD thesis. Florida State University, Tallahassee, FL.
55. Tian, F., and T. A. Cross. 1997. Dipolar oscillations in cross-polarized peptide samples in oriented lipid bilayers. J. Magn. Reson. 125:220-223.
56. Kolodziejski, W., and J. Klinowski. 2002. Kinetics of cross-polarization in solid-state NMR: a guide for chemists. Chem. Rev. 102:613-628.
57. Ernst, R. R., G. Bodenhausen, and A. Wokaun. 1987. Principles of Nuclear Magnetic Resonance in One and Two Dimensions. Oxford University Press, Oxford.
58. Demco, D. E., J. Tegenfeldt, and J. S. Waugh. 1975. Dynamics of cross relaxation in nuclear magnetic double-resonance. Phys. Rev. 11:4133-4151.
59. Alemany, L. B., D. M. Grant, T. D. Alger, and R. J. Pugmire. 1983. Cross-polarization and magic angle sample spinning NMR-spectra of model organic compounds. 3. Effect of the C-13-H-1 dipolar interaction on cross-polarization and carbon-proton dephasing. J. Am. Chem. Soc. 105:6697-6704.
60. Reynolds, W. F., I. R. Peat, M. H. Freedman, and J. R. Lyerla. 1973. Determination of tautomeric form of imidazole ring of L-histidine in basic solution by C-13 magnetic-resonance spectroscopy. J. Am. Chem. Soc. 95:328-331.
61. Song, X. J., and A. E. McDermott. 2001. Proton transfer dynamics and N-H bond lengthening in N-H⋯N model systems: a solid-state NMR study. Magn. Reson. Chem. 39:S37-S43.
62. 2+ transporter. Nature. 440:833-837.